Zobrazeno 1 - 10
of 76 073
pro vyhledávání: '"Primary Sclerosing Cholangitis"'
Autor:
Mandea, Matei1,2,3 (AUTHOR) matei.mandea@drd.umfcd.ro, Iacob, Speranta Maria1,2,3 (AUTHOR), Grasu, Mugur Cristian2,4 (AUTHOR) mugur.grasu@gmail.com, Anghel, Cristian2,4 (AUTHOR), Iacob, Razvan Andrei1,2,3 (AUTHOR), Ghioca, Mihaela Corina1,2,3 (AUTHOR), Gheorghe, Cristian1,2,3 (AUTHOR), Gheorghe, Liliana Simona1,2,3 (AUTHOR)
Publikováno v:
Journal of Clinical Medicine. Aug2024, Vol. 13 Issue 15, p4548. 13p.
Autor:
E. S. Pak, T. M. Petrova, R. V. Korobka, A. A. Ushakov, O. B. Kucherenko, V. Yu. Katsiyaev, O. V. Bukhtin
Publikováno v:
Медицинский вестник Юга России, Vol 15, Iss 3, Pp 97-105 (2024)
Primary sclerosing cholangitis (PSC) is a disease characterized by inflammation, fibrosis and obliteration of both intra- and extrahepatic bile ducts, accompanied by cholestasis, with further outcome in biliary cirrhosis of the liver, cholangiocarcin
Externí odkaz:
https://doaj.org/article/9070a933903841cdb5d6b2a329b27179
Autor:
Kalthoff, Sandra1 (AUTHOR) sandra.kalthoff@ukbonn.de, Wolniak, Caroline1 (AUTHOR), Lutz, Philipp1 (AUTHOR), Strassburg, Christian P.1 (AUTHOR), Langhans, Bettina1,2 (AUTHOR), Dold, Leona1,2 (AUTHOR)
Publikováno v:
BMC Gastroenterology. 8/5/2024, Vol. 24 Issue 1, p1-8. 8p.
Autor:
Mousavere, Ioanna1 gianna_mousa@hotmail.com, Kalampokis, Georgios2, Fousekis, Fotios1, Karayiannis, Peter3, Baltayiannis, Gerasimos1, Christodoulou, Dimitrios1
Publikováno v:
Annals of Gastroenterology. 2023, Vol. 36 Issue 6, p589-598. 10p.
Autor:
Leighton, Jessica1 (AUTHOR) jessleighton@live.co.uk, Jones, David E. J.1,2 (AUTHOR), Dyson, Jessica K.1,2 (AUTHOR), Cordell, Heather J.3 (AUTHOR)
Publikováno v:
BMC Medical Genomics. 6/11/2024, Vol. 17 Issue 1, p1-13. 13p.
Autor:
Zhou, Jie1,2 (AUTHOR), Zhu, Dagang1,2 (AUTHOR) doctorzdg@126.com, Xu, Yixin1,2 (AUTHOR), Chen, Chao1,2 (AUTHOR), Wang, Kun1,2 (AUTHOR)
Publikováno v:
BMC Gastroenterology. 5/8/2024, Vol. 24 Issue 1, p1-9. 9p.
Publikováno v:
Open Medicine, Vol 19, Iss 1, Pp 2547-59 (2024)
No intervention definitively extends transplant-free survival in primary sclerosing cholangitis (PSC). Statins, inhibitors of 3-hydroxy-3-methylglutaryl coenzyme A reductase (HMGCR), may enhance PSC prognosis, but their efficacy is debated.
Externí odkaz:
https://doaj.org/article/bc06fd3e41234b4789ad5dc19ef1b1c4
Autor:
Ziwen Pan, Weijie Zhang
Publikováno v:
European Journal of Medical Research, Vol 29, Iss 1, Pp 1-8 (2024)
Abstract Background Observational studies have found a link between two autoimmune diseases, namely, primary sclerosing cholangitis (PSC) and systemic lupus erythematosus (SLE). However, the relationship remains unclear. Methods Bidirectional Mendeli
Externí odkaz:
https://doaj.org/article/2fc9845b12b94c8fb9fa524f4801db44